Table 1 Comparison of clinicopathologic characteristics according to the LETM1 expression in non-small cell lung carcinoma tissues
From: LETM1 is a potential biomarker of prognosis in lung non-small cell carcinoma
Variable | n | LETM1 (−) n(%) | LETM1 (+) n(%) | χ2 | R | p-value |
|---|---|---|---|---|---|---|
Sex | 0.186 | 0.048 | 0.666 | |||
Female | 23 | 8 (34.8) | 15 (65.2) | |||
Male | 52 | 22 (42.3) | 30 (57.7) | |||
Age (years) | 1.851 | 0.149 | 0.174 | |||
≤ 65 | 35 | 17 (48.6) | 18 (51.4) | |||
>65 | 40 | 13 (32.5) | 27 (67.5) | |||
Size (cm) | 0.005 | 0.008 | 0.946 | |||
≤ 4 | 43 | 17 (39.5) | 26 (60.5) | |||
>4 | 32 | 13 (40.6) | 19 (59.4) | |||
pT stage | 5.774 | 0.242 | 0.056 | |||
T1 | 4 | 2 (50.0) | 2 (50.0) | |||
T2 | 63 | 28 (44.4) | 35 (55.6) | |||
T3 | 8 | 0 (0.0) | 8 (100.0) | |||
Lymph node metastasis | 8.576 | 0.334 | 0.003 | |||
Negative | 56 | 27 (48.2) | 29 (51.8) | |||
Positive | 19 | 3 (15.8) | 16 (84.2) | |||
Clinical stage | 10.772 | 0.364 | 0.005 | |||
I | 55 | 28 (50.9) | 27 (49.1) | |||
II | 16 | 2 (12.5) | 14 (87.5) | |||
III | 4 | 0 (0.0) | 4 (100.0) |